Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype
Open Access
- 5 July 2005
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 75 (2) , 93-100
- https://doi.org/10.1111/j.1600-0609.2005.00507.x
Abstract
Abstract: Fanconi anaemia (FA) is a genetic disease characterised by bone marrow failure with excess risk of myelogenous leukaemia and solid tumours. A widely accepted notion in FA research invokes a deficiency of response to DNA damage as the fundamental basis of the ‘crosslinker sensitivity’ observed in this disorder. However, such an isolated defect cannot readily account for the full cellular and clinical phenotype, which includes a number of other abnormalities, such as malformations, endocrinopathies, and typical skin spots. An extensive body of evidence pointing toward an involvement of oxidative stress in the FA phenotype includes the following: (i)In vitroandex vivoabnormalities in a number of redox status endpoints; (ii) the functions of several FA proteins in protecting cells from oxidative stress; (iii) redox‐related toxicity mechanisms of the xenobiotics evoking excess toxicity in FA cells. The clinical features in FA and thein vivoabnormalities of redox parameters are here reconsidered in view of the pleiotropic clinical phenotype and known biochemical and molecular links to anin vivoprooxidant state, which causes oxidative damage to biomolecules, resulting in an excessive number of acquired abnormalities that may overwhelm the cellular repair capacity rather than a primary deficiency in DNA repair. FA may thus represent a unique model disease in testing the integration between the acquisition of macromolecular damage as a result of oxidative stress and the ability of the mammalian cell to respond effectively to such damage.Keywords
This publication has 71 references indexed in Scilit:
- X-linked inheritance of Fanconi anemia complementation group BNature Genetics, 2004
- DNA damage and repair in type 2 diabetes mellitusMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic PathwayJournal of Biological Chemistry, 2004
- Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sitesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokinesBlood, 2003
- Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instabilityOncogene, 2002
- Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutaneFEBS Letters, 1998
- Cell Cycle Defect in Connection with Oxygen and Iron Sensitivity in Fanconi Anemia Lymphoblastoid CellsExperimental Cell Research, 1996
- In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia familiesCarcinogenesis: Integrative Cancer Research, 1995
- Suppression of cylotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblastsCarcinogenesis: Integrative Cancer Research, 1982